Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study
- PMID: 34582029
- DOI: 10.1007/s13346-021-01072-8
Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study
Abstract
The research work was driven to develop, optimize, and characterize novel nanostructured liquid crystalline particles as carriers for the ocular delivery of vancomycin. The formulations were developed by fragmenting the cubic crystalline phase of glycerol monooleate, water, and poloxamer 407. A four-factor, three-level Taguchi statistical experimental design was constructed to optimize the formulation. Formulations exhibited internal-cubic structure of the vesicles with particle size in the range of 51.11 ± 0.96 nm to 158.73 ± 0.46 nm and negative zeta potential. Ex vivo transcorneal permeation studies demonstrated that the optimized cubosomes had a 2.4-fold increase in apparent permeability co-efficient as compared to vancomycin solution, whereas in vivo studies in rabbits demonstrated that the severity of keratitis was considerably lowered on day 3 with optimized cubosomes. Ocular pharmacokinetic studies evaluated the level of drug in aqueous humor, and results revealed that the time to peak concentration (Tmax) of vancomycin-loaded cubosomal formulation was about 1.9-fold higher and mean residence time was 2.2-fold greater than vancomycin solution. Furthermore, histological examination revealed that the corneal layers displayed well-maintained morphology without any stromal swelling, consequently indicating the safety of formulation. It could be concluded that the developed nanostructured liquid crystalline particles of vancomycin demonstrated improved pre-ocular residence time, increased permeability, reduced dosing frequency, controlled drug release, and reduced systemic side-effects. Results manifested that the developed vancomycin-loaded cubosomes could be a promising novel ocular carrier and an ideal substitute for conventional eye drops for the management of bacterial-keratitis.
Keywords: Bacterial keratitis; HET-CAM test; Histopathological studies; Nanostructured liquid crystalline particles; Ocular pharmacokinetic studies.
© 2021. Controlled Release Society.
References
-
- Anutra M, Somsanguan A, Phuriwat L, Chutiporn L, Robert M. Chitosan as an ocular drug delivery vehicle for vancomycin. J Appl Polym Sci. 2019;122:3160-3167. https://doi.org/10.1002/app.34323 . - DOI
-
- Zavarshani M, Ahmadi M, Saei HD, Tehrani AA, Naghadeh BD. Comparison therapeutic effects of ciprofloxacin, silver nanoparticles and their combination in the treatment of Pseudomonas keratitis in rabbit: an experimental study. Iran J Pharm Res. 2019;18(1);320–327. https://doi.org/10.22037/IJPR.2019.2328 .
-
- Pooja P, Roma M, Sreeja MK. Development and optimisation of quercetin cubosomes incorporated in glyceryl monooleate aided by design expert software. Ijppr.Human. 2018;11(4):80-106. https://www.ijppr.humanjournals.com/wpcontent/uploads/2018/04/8.Pooja-Po... .
-
- Swati C, Neha G, Upendra N. Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery. Int J Polym Mater Polym Bioma. 2018;68(5):266-277. https://doi.org/10.1080/00914037.2018.1443932 . - DOI
-
- Nilesh RR, Suprit DS, Nishikant AR, Jayashree BT, Pramod BK, Vivek SD. Nanostructured cubosomes in a thermoresponsive depot system: an alternative approach for the controlled delivery of docetaxel. AAPS PharmSciTech. 2016;17(2):436-445. https://doi.org/10.1208/s12249-015-0369-y . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources